Antiparkinson potential of -opioid receptor agonists

By Hudzik T.J.   Howell A.   Payza K.   Cross A.J.  

European Journal of Pharmacology, Vol. 396, Iss. 2, 2000-05 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite

Dopamine D1 receptor agonists induce penile erections in rats

By D'Aquila P.S.   Panin F.   Cossu M.   Peana A.T.   Serra G.  

European Journal of Pharmacology, Vol. 460, Iss. 1, 2003-01 ,pp. : 71-74

Elsevier

Access to resources Recommend Favorite

Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D 1 receptor agonists A-86929 and ABT-431

By Shiosaki K.   Asin K.E.   Britton D.R.   Giardina W.J.   Bednarz L.   Mahan L.   Mikusa J.   Nikkel A.   Wismer C.  

European Journal of Pharmacology, Vol. 317, Iss. 2, 1996-12 ,pp. : 183-190

Elsevier

Access to resources Recommend Favorite

In vivo characterization of novel full and partial 2-(4-aminophenyl)-N,N-dipropylethylamine dopamine D 2 receptor agonists 1

By Ahlenius S.   Ericson E.   Florvall L.   Jimenez P.   Hillegaart V.   Wijkstrom A.  

European Journal of Pharmacology, Vol. 394, Iss. 2, 2000-04 ,pp. : 247-253

Elsevier

Access to resources Recommend Favorite

Inhibition of dopamine neuron firing by pramipexole, a dopamine D 3 receptor-preferring agonist: comparison to other dopamine receptor agonists

By Piercey M.F.   Hoffmann W.E.   Smith M.W.   Hyslop D.K.  

European Journal of Pharmacology, Vol. 312, Iss. 1, 1996-09 ,pp. : 35-44

Elsevier

Access to resources Recommend Favorite